GoodRx (NASDAQ:GDRX) Shares Up 5.5% – Should You Buy?

Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) shot up 5.5% during trading on Wednesday . The stock traded as high as $4.65 and last traded at $4.73. 100,978 shares changed hands during trading, a decline of 92% from the average session volume of 1,326,227 shares. The stock had previously closed at $4.48.

Analyst Upgrades and Downgrades

GDRX has been the topic of several recent research reports. Mizuho initiated coverage on GoodRx in a report on Wednesday, December 4th. They issued a “neutral” rating and a $5.00 price target on the stock. KeyCorp decreased their price target on GoodRx from $7.00 to $6.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Morgan Stanley decreased their price target on GoodRx from $7.00 to $6.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Wells Fargo & Company decreased their price target on GoodRx from $9.00 to $8.00 and set an “overweight” rating on the stock in a report on Friday, February 28th. Finally, Citigroup cut their target price on GoodRx from $7.00 to $6.25 and set a “buy” rating on the stock in a research note on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, GoodRx has an average rating of “Moderate Buy” and an average target price of $8.18.

GoodRx Stock Performance

The company has a market cap of $1.83 billion, a price-to-earnings ratio of -158.83, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. The company has a debt-to-equity ratio of 0.70, a current ratio of 5.48 and a quick ratio of 5.48. The stock has a 50-day moving average price of $4.72 and a 200 day moving average price of $5.46.

Institutional Investors Weigh In On GoodRx

Hedge funds have recently modified their holdings of the business. National Bank of Canada FI raised its position in shares of GoodRx by 34.9% during the fourth quarter. National Bank of Canada FI now owns 8,308 shares of the company’s stock worth $39,000 after purchasing an additional 2,151 shares during the period. EP Wealth Advisors LLC acquired a new stake in GoodRx in the 3rd quarter valued at approximately $73,000. RPO LLC acquired a new stake in GoodRx in the 4th quarter valued at approximately $52,000. Versor Investments LP acquired a new stake in GoodRx in the 4th quarter valued at approximately $54,000. Finally, Verus Capital Partners LLC acquired a new stake in GoodRx in the 4th quarter valued at approximately $55,000. Institutional investors and hedge funds own 63.77% of the company’s stock.

About GoodRx

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.